The AmBulatory Closure Device Percutaneous Intervention (ABCD-PCI) study: a single-center experience

The management of patient discharge after percutaneous coronary intervention has long been a focus of clinical research. Prior studies have explored the feasibility of early discharge following such procedures. However, the balance between patient safety and convenience remains unclear. No prior work had resolved whether same-day discharge is as safe as next-day discharge. This uncertainty drove the need for a controlled trial. The use of closure devices has been linked to reduced vascular complications. Still, the impact on patient-reported outcomes was not well established. This gap motivated the ABCD-PCI study. The study aimed to address this by comparing two discharge strategies. The findings from a single center provide insights into this debate.

The ABCD-PCI study aimed to assess the safety and patient satisfaction of same-day discharge after percutaneous intervention using a closure device. The specific problem addressed was whether early discharge could be implemented without compromising outcomes. The motivation stemmed from the need to improve patient convenience. The study compared same-day and next-day discharge groups. The goal was to determine if both approaches were equally safe. Researchers also wanted to evaluate patient-reported comfort levels. The trial was conducted at a single center to control for variability. The findings contribute to evidence-based discharge protocols.

The ABCD-PCI study was a prospective controlled trial with two groups. One group received same-day discharge, and the other had next-day discharge. Both groups underwent percutaneous intervention with a closure device. Patient outcomes were assessed using a structured questionnaire. Follow-up occurred at 7 and 30 days via phone calls. Demographic and procedural data were collected for both groups. No significant differences were found between the groups. The study focused on safety and satisfaction metrics.

Results showed no significant differences in safety outcomes between the two groups. Same-day discharge was as safe as next-day discharge in this setting. Patient satisfaction was measured through self-reported comfort levels. A trend suggested higher comfort in the next-day group. No major adverse events were reported in either group. Follow-up data supported the safety of early discharge. The study included 23 same-day and 21 next-day patients. These findings support the feasibility of same-day discharge.

The authors concluded that same-day discharge after percutaneous intervention with a closure device is as safe as next-day discharge. The findings suggest that early discharge can be implemented without risk. Patient comfort levels showed a trend favoring next-day discharge. The study supports the use of closure devices in this context. The results are limited to a single-center experience. No generalizations beyond this setting were made. The authors emphasized the importance of patient-reported outcomes. These conclusions are based on the observed data from the trial.